Crude oil prices are in the spotlight this week as the deal between the United States and Iran is tested. Brent, the global benchmark, ended the week at $73.6, down sharply from year-to-date high of $119.4. WTI has moved below the key support level of $70. US and Iran exchange strikes There are signs that
South Korean stocks have soared in the past few months, with the KOSPI Index doubling this year, helped by the strong performance of Samsung and SK Hynix. It peaked at 9,388 this month and then pulled back to the current 8,410. Still, there is a risk that the index will retreat sharply once the ongoing
Bitcoin price retreated below the important support of $60,000 as concerns about demand from American investors continued. BTC was trading at $59,930, lower from last month’s high of $82,803. So, will the retreat continue as ETF outflows jump? Bitcoin ETF outflows are surging There are signs that American investors are aggressively selling their Bitcoin positions.
The S&P 500 Index has come under pressure in the past few days, moving from the year-to-date high of $7,620 to the current $7,354. This retreat continued amid the rising jitters that the AI boom is ending. This article highlights some of the top catalysts for the index and its ETFs like VOO and SPY.
Sellas Life Sciences (SLS) shares are extending gains on Jun. 26 following a key regulatory filing that disclosed a series of comprehensive corporate amendments regarding executive compensation and protection. Specifically, the board restructured change-of-control and severance agreements for CEO Angelos Stergiou, CFO John Burns, and CDO Dragan Cicic. The marketplace is widely interpreting these sudden
Around two weeks ago, Elon Musk’s SpaceX conglomerate went public. Everyone who is remotely interested has a fair idea of the numbers. But in a nutshell, it was easily the biggest Initial Public Offering (IPO) in history. It also led to Mr Musk becoming the first ever trillionaire, however briefly. Without doubt, the whole SpaceX
Shares of SpaceX (SPCX) rose 3% on Friday as investors prepared for the company’s addition to the Russell 1000 Index. The move is expected to drive demand from passive investment funds and broaden the stock’s presence across major benchmarks. The gains came after a difficult stretch for the newly public company. The stock surged to
Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard. Investors are bailing on OMER mostly because the European Medicines Agency’s (EMA) expert panel has rejected its primary commercial asset. At the time of writing, Omeros stock is down some 50% versus the
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains followed the company’s Science Day presentation and investor event, where Moderna outlined an ambitious strategy to expand beyond its COVID-19 vaccine business and
Ripple has reported a sharp increase in tokenised assets issued on the XRP Ledger, highlighting growing institutional interest in blockchain-based financial products even as XRP continues to face pressure in the broader cryptocurrency market. The value of tokenised real-world assets (RWAs) on the XRP Ledger rose from about $5 million at the start of 2025